Now Credit Card Companies Want Your DNA
By Martha C. White,
Time: Moneyland
| 10. 27. 2011
A
Wall Street Journal article earlier this week reported that Visa and MasterCard are exploring new ways to take data about your buying habits in the brick-and-mortar world and let online marketers use that information to target you with ads when you browse the web. But buried a little ways down in the article are some details that are considerably more alarming. Visa, the article says, wants access to everything from your insurance claim history to your Facebook friends list to your DNA. Yes, you read that right:
According to a Visa patent application published in April, the company sees potential to use a wide array of personal details to create profiles that could be used for ad targeting well beyond shopping details. It describes the possibility of also using “information from social network websites, information from credit bureaus, information from search engines, information about insurance claims, information from DNA databanks,” and other sources.
This is a huge can of worms, warns Lillie Coney, associate director of the Electronic Privacy Information Center. “This is going to be problematic,” she says...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026